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Abstract
The Knee injury and Osteoarthritis Outcome Score (KOOS) was developed as an extension of the
WOMAC Osteoarthritis Index with the purpose of evaluating short-term and long-term symptoms
and function in subjects with knee injury and osteoarthritis. The KOOS holds five separately scored
subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation
(Sport/Rec), and knee-related Quality of Life (QOL). The KOOS has been validated for several
orthopaedic interventions such as anterior cruciate ligament reconstruction, meniscectomy and
total knee replacement. In addition the instrument has been used to evaluate physical therapy,
nutritional supplementation and glucosamine supplementation. The effect size is generally largest
for the subscale QOL followed by the subscale Pain. The KOOS is a valid, reliable and responsive
self-administered instrument that can be used for short-term and long-term follow-up of several
types of knee injury including osteoarthritis. The measure is relatively new and further use of the
instrument will add knowledge and suggest areas that need to be further explored and improved.
The Knee injury and Osteoarthritis Outcome 
Score (KOOS)
Why assess Health-Related Quality of Life with the Knee 
Injury and Osteoarthritis Outcome Score (KOOS)?
The main reason for developing a single instrument with
the purpose of covering several types of knee injury and
including osteoarthritis (OA), was that traumatic knee
injuries often causes concomitant damage to multiple
structures (ligaments, menisci, cartilage, etc.) and fre-
quently lead to the later development of OA. To be able to
follow patients after a trauma and to gain insight into the
change of symptoms, function etc. over time, a question-
naire which covers both the short-term and long-term
consequences is needed. Prior instruments such as the
Lysholm knee scoring scale [1] have focused only on the
short-term consequences and instruments such as the
WOMAC Osteoarthritis Index [2] only on the long-term
consequences. An instrument intended for follow-up of
these patients needs to adequately monitor both the acute
injury consequences in the physically active and younger
patients, and the chronic outcome in the older.
What is the KOOS?
The KOOS is a knee-specific instrument, developed to
assess the patients' opinion about their knee and associ-
ated problems. The KOOS evaluates both short-term and
long-term consequences of knee injury. It holds 42 items
in 5 separately scored subscales; Pain, other Symptoms,
Function in daily living (ADL), Function in Sport and Rec-
reation (Sport/Rec), and knee-related Quality of Life
(QOL).
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How was the KOOS developed?
The KOOS was originally developed in 1995 by Ewa M
Roos and colleagues at the Departments of Orthopaedics
at Lund University, Sweden and at the University of Ver-
mont, USA. Thus, the American-English and Swedish ver-
sions were developed simultaneously.
To ensure content validity for subjects with ACL injury,
meniscus injury, and early OA, we reviewed the literature,
consulted an expert panel, and conducted a pilot study
(Fig. 1). The literature indicated three principal areas of
patient-relevant outcomes: symptoms, functional status,
and satisfaction. An expert panel comprised of patients
referred to physical therapy because of knee injuries,
orthopaedic surgeons, and physical therapists from both
Sweden and the United States, was asked to identify short-
and long-term symptoms and functional disabilities
resulting from a meniscus or ACL injury. Seven factors
were identified by the panel: pain, early disease-specific
symptoms, late disease-specific symptoms (e.g. symptoms
of OA), function, quality of life, activity level, and
satisfaction.
Development and evaluation of the KOOS Figure 1
Development and evaluation of the KOOS.
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A pilot study was then conducted to identify the subjec-
tively most relevant factors among patients with post-trau-
matic osteoarthritis. Seventy-five individuals who had
had meniscus surgery 20 years previously were asked to
respond to two questionnaires, both self-administered.
The participants ranged in age from 35 to 76 (mean 56),
and showed radiological signs of knee OA, defined as
joint space narrowing and osteophytes. One of the ques-
tionnaires, by Flandry et al. [3], was constructed to assess
symptoms of anterior cruciate ligament (ACL) injury and
the other, WOMAC Osteoarthritis Index [2], for assessing
symptoms of knee OA Questions that most frequently
received high responses, and were thus considered to
reflect the most predominant symptoms, included those
relating to pain, swelling, stiffness, and the ability to run,
jump, kneel, and squat.
To be able to calculate WOMAC scores from the KOOS,
the questions from the WOMAC Osteoarthritis Index LK
3.0 [2] were included in their full and original form in the
KOOS questionnaire (with permission, Nicholas Bellamy
personal communication 1995). The KOOS dimension of
Activities of Daily Living is equivalent to that of Function
in the WOMAC Osteoarthritis Index. Questions included
in the subscales Sport and Recreational Function and
knee-related Quality of Life were adopted, in their original
form or with some modification, from other outcome
measures used to assess ACL injury [3,4]. Satisfaction and
activity level, two dimensions also considered relevant by
the panel of experts, were not included in the KOOS, since
it was not possible to agree on wording that would be
applicable for all situations.
How was the KOOS validated?
The KOOS has been validated in several different popula-
tions having surgical procedures due to knee complaints.
To ensure the instrument being valid for both short-term
and long-term consequences, validations have been car-
ried out in different populations with varying diseases and
durations and at varying ages and activity levels. Firstly,
the American-English version was validated in subjects
(age range 18–46) undergoing surgical reconstruction of
the ACL [5]. Secondly, the Swedish version was validated
in subjects (age range 16–79) undergoing knee arthros-
copy [6]. Thirdly, the KOOS was compared to the
WOMAC in subjects meniscectomized 16 years previously
(age range 38–76) with and without OA [7]. Fourthly, a
validation study was carried out in subjects (age range 43–
86) treated with total knee replacement for OA [8]. For
patients on the waiting-list for total knee replacement for
OA, content validity was assessed before surgery by asking
the patients to rate the importance of improvement in
each of the five KOOS subscales on a 5-point Likert-scale
as extremely important, very important, moderately
important, somewhat important, or not important at all.
For each subscale examples of questions within the sub-
scale were given. Over 90% reported that improvement in
the four subscales Pain, Symptoms, Activities of Daily Liv-
ing, and knee-related Quality of Life was extremely or very
important when deciding to have their knee operated on.
51% reported that improvement in functions included in
the subscale Sport and Recreation Function such as squat-
ting, kneeling, jumping, turning/twisting and running
was extremely or very important when deciding to have
their knee operated on. Postoperatively, patients tended
to start doing physical functions they did not do prior to
the operation.
Convergent and divergent construct validity was deter-
mined in comparison to the SF-36 [9], and when applica-
ble also to the Lysholm knee scoring scale [1].
What translations are available?
The KOOS has been formally validated in American-Eng-
lish [5], Swedish [6] and German [10]. Translations are
also available in Danish, Russian and Italian. Spanish,
French, Icelandic, Polish, Estonian and Greek versions are
pending.
What modifications for other joints and diseases are 
available?
The KOOS has been modified to assess problems associ-
ated with the foot and ankle (FAOS) [11] and with the hip
HOOS [12]. A modification intended for evaluation of
lower extremity problems (hip, knee and foot) in subjects
with rheumatoid arthritis and other inflammatory joint
diseases (RAOS) has recently been published [13].
Symptoms experienced from the hip differs to some
extent from symptoms experiences from the knee and foot
which is reflected by differences in the symptoms subscale
of the HOOS compared to the other modifications. Swell-
ing, range of motion, and mechanical symptoms were not
included in the HOOS due to low relevance and respon-
sivenss. With regard to physical activities however there
were only minor differences between the HOOS and the
other modifications.
Why is the KOOS a good instrument to consider using?
The KOOS is a comprehensive instrument including five
subscales assessing aspects of knee injury and knee OA
considered important by patients. Most other instruments
used for acute knee injury aggregate items measuring dif-
ferent aspects into one score. This procedure flattens the
results and makes interpretation more difficult since the
included items do not always correlate. The KOOS is self-
administered and takes approximately 10 minutes to fill
out. It is a feasible instrument as illustrated by few missing
items, 0.8% for subjects having knee arthroscopy and
3.2% for subjects having total knee replacement, whenHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/64
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administered by mail [6,8]. Since a subscore can be calcu-
lated when two or less items are missing for each subscale,
it was only in a few cases a subscore could not be
calculated.
Patients sustaining knee joint injury are often young and
physically active. An advantage when using the KOOS for
studies of the long-term consequences of joint injury in
such patients is that the KOOS assesses sport and recrea-
tion function and knee-related quality of life and has a
greater responsiveness compared to other more generic
instruments such as the WOMAC and the SF-36 (Fig 2).
What are the applications of the KOOS?
The KOOS is intended to be used over short and long time
intervals; to assess changes from week to week induced by
treatment (medication, surgery, physical therapy) or over
the years due to a primary knee injury, posttraumatic OA
or primary OA.
What areas of health does it measure?
The KOOS collects data on five knee-specific patient-cen-
tered outcomes: (1) pain; (2) other symptoms such as
swelling, restricted range of motion and mechanical
symptoms; (3) disability on the level of daily activities;
(4) disability on a level physically more demanding than
activities of daily living; (5) mental and social aspects
such as awareness and lifestyle changes.
Who answers it?
The KOOS is self-administered and filled out by the
patient. In the Swedish validation studies the question-
naires have been sent and returned by mail. In the Ameri-
can validation study the questionnaires were either filled
Effect sizes of KOOS, WOMAC and SF-36 six months after ACL-reconstruction Figure 2
Effect sizes of KOOS, WOMAC and SF-36 six months after ACL-reconstruction. Comparison of effect sizes of 
KOOS, WOMAC and SF-36 six months after surgical reconstruction of the ruptured anterior cruciate ligament. Effect size was 
defined as mean score change divided by the pre-operative standard deviation. The data are previously published (n = 21, mean 
age 32 years) [5]. Placebo or sham treatment results have not been subtracted to generate effect sizes. It should be noted that 
the effect size displayed here will be influenced by the preoperative within-group variation of the score dimension measured.
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out prior to a doctors visit or by mail. No interview or
phone formats are available.
How long does it take to complete the KOOS?
The KOOS takes about 10 minutes to fill out.
How is the KOOS administered?
The KOOS is self-explanatory and can be administered in
the waiting room or used as a mailed survey.
How is the KOOS scored?
The five patient-relevant subscales of KOOS are scored
separately: Pain (nine items); Symptoms (seven items);
ADL Function (17 items); Sport and Recreation Function
(five items); Quality of Life (four items). A Likert scale is
used and all items have five possible answer options
scored from 0 (No Problems) to 4 (Extreme Problems)
and each of the five scores is calculated as the sum of the
items included. Scores are transformed to a 0–100 scale,
with zero representing extreme knee problems and 100
representing no knee problems as common in orthopae-
dic assessment scales and generic measures. Scores
between 0 and 100 represent the percentage of total pos-
sible score achieved. An aggregate score is not calculated
since it is regarded desirable to analyze and interpret the
five dimensions separately.
Is there automated administration or scoring software?
Scoring software is available in Microsoft Excel-format
and can be downloaded from http://www.koos.nu
How are the KOOS scores interpreted?
The score is a percentage score from 0 to 100, 0 represent-
ing extreme problems and 100 representing no problems.
This direction, 100 indicating no problems, is common in
orthopaedic instruments and generic measures like the SF-
36. In measures developed by rheumatologists, like the
WOMAC, 100 usually represents worst possible result.
Is the KOOS responsive to change?
Change over time
The effect sizes following surgical procedures vary both
with regard to the procedure being undertaken and the
specific KOOS subscale. Generally, the subscale QOL is
the most responsive, followed by the subscale Pain. The
highest effect sizes observed were obtained after total knee
replacement (Figure 3).
Between-group differences
Several randomized trials using the KOOS have been pub-
lished. In a trial comparing two methods of reconstruc-
tion of the ACL, significant differences between groups
were found in ADL, Sport/Rec and QOL at various postop-
erative time points [14]. In a trial of glucosamine supple-
mentation, significant group differences were found in
Pain and ADL [15]. In a trial of a nutritional supplement
significant between-group differences were found for ADL
[16]. In all trials, significant improvement was detected in
the treatment groups over time. The number of subjects in
each treatment arm in these RCT:s ranged from 15 to 27.
In a study on continuous passive motion as supplemental
treatment following total knee replacement, no signifi-
cant differences were found between groups [17].
What is the meaningful change for the instrument?
The minimal perceptible clinical improvement (MPCI)
represents the difference on the measurement scale asso-
ciated with the smallest change in the health status detect-
able by the patient. The MPCI of the KOOS has not been
formally assessed. Since the KOOS questionnaire contains
the full and original version of the WOMAC index and
WOMAC scores can easily be calculated, the MPCI of
approximately 10 obtained for the WOMAC [18] has been
applied to KOOS in power analyses and when determin-
ing cut-offs for improvement and deterioration (Parad-
owski P et al., personal communication 2003).
Accordingly, a level of 10 points or more of improvement
or decline was suggested as a cut-off representing a clini-
cally significant difference.
In support of this suggestion, we compared KOOS data
after ACL reconstruction with the clinical knowledge of
rehabilitation phases following ACL reconstruction. Three
months postoperatively, the patients experienced some
pain, swelling and restriction in range of motion and had
not pushed their knee during sporting activities. This was
reflected by (statistically non-significant) changes of 1 to
7 KOOS score points in pain, symptoms, and sport and
recreation function over this time interval, compared to
preoperative scores. Six months postoperatively, the
patients were back at more vigorous activities including
sport and had few symptoms, reflected by (statistically sig-
nificant) changes of 8–23 score points in all subscale
scores. Thus, it seems that a change in score of 8 points or
more may represent a clinically significant change follow-
ing ACL reconstruction. We thus suggest that 8–10 points
may represent the minimal perceptible clinical improve-
ment (MPCI) of the KOOS. However, to further explore
this difficult question, additional studies including differ-
ent treatments and patient groups should be undertaken.
Has the KOOS been used in individual patients?
The test-retest reliability has been sufficient for most sub-
scales in most studies to allow assessment of change over
time in individual patients. The KOOS is frequently used
in the clinic to help patients and therapists follow the
progress after interventions due to knee problems.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/64
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In which populations has the KOOS been used?
The KOOS is intended to be used in knee injury that can
result in post traumatic OA or in primary OA. The KOOS
has been used in men and women ranging from 14–79
years in age with varying disorders resulting in knee com-
plaints such as anterior cruciate ligament tear, meniscus
tear, and mild, moderate and severe OA. The KOOS has
been used to follow the immediate post-operative period
and in 10 to 20 year follow-ups of knee injury. The KOOS
was published in 1998, and in prospective studies of knee
injury no longer follow-ups than 2 years have been pub-
lished to date. The KOOS has also been used in healthy
female soccer players [19]. By others, the KOOS has been
used to assess the effects of anterior cruciate ligament
Effect size for different surgical interventions measured by KOOS Figure 3
Effect size for different surgical interventions measured by KOOS. KOOS effect sizes 6 months following surgical 
knee interventions. Effect size was defined as mean score change divided by the pre-operative standard deviation. The data 
from total knee replacement [8] (n = 105, mean age 71.3 years) and anterior cruciate ligament reconstruction [5] (n = 21, 
mean age 32 years) are previously published. The data from tibial osteotomy concerns 50 patients (mean age 54 years) under-
going hemicallotasis osteotomy (W-Dahl A, Lund University, personal communication 2001). The data from cartilage repair 
concerns 50 patients (mean age 34 years) undergoing autologus cartilage transplant (Olsson M, University of Gothenburg, per-
sonal communication 2002). The data for meniscectomy concern 66 patients (mean age 44 years) undergoing arthroscopic par-
tial meniscectomy (Roos E, Lund University, personal communication 2003). Placebo or sham treatment results have not been 
subtracted to generate effect sizes. It should be noted that the effect size displayed here will be influenced by the preoperative 
within-group variation of the score dimension measured. This may vary between the different study groups. All data are pub-
lished with permission from the authors.
-0.5
0
0.5
1
1.5
2
2.5
3
Pain
Symptoms
ADL
Sport/Rec
QOL
E
f
f
e
c
t
 
s
i
z
e
Arthroplasty
Tibial Osteotomy
ACL-reconstruction
Meniscectomy
Autologous Cartilage
TransplantationHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/64
Page 7 of 8
(page number not for citation purposes)
reconstruction [14], glucosamine supplementation [15],
and nutritional supplementation [16].
Do we need permission to use it?
Permission is not required to use the KOOS.
Who may I contact to obtain a copy of the KOOS?
The KOOS questionnaire including modifications for the
foot and ankle (FAOS), hip (HOOS) and rheumatoid and
other types of arthritis (RAOS) can be downloaded from
http://www.koos.nu
How can we obtain more information about the KOOS?
Please go to http://www.koos.nu
How much does it cost to purchase the KOOS itself?
The KOOS is free of charge.
How can we obtain a scientific support during our study?
Information is available at http://www.koos.nu
Discussion
The KOOS was first published in 1998, and is thus a rela-
tively new instrument. Its use in several different patient
groups is supported by the currently available literature.
However, further use of the instrument will add knowl-
edge and suggest areas that need to be further explored
and improved.
KOOS vs. WOMAC
The KOOS was developed as an extension of the WOMAC
Osteoarthritis Index with the overall purpose to evaluate
short- and long-term symptoms and function after knee
injury and OA. The reason for developing one instrument
covering several types of knee injury and OA was that
these structural damages often coincide within patients.
All the questions of the WOMAC LK 3.0 were retained so
that a WOMAC score might be calculated separately and
compared with the KOOS score. This would also facilitate
comparison of outcomes with previous studies using
WOMAC on other patient populations.
Knee injury most often includes damage to the ligaments,
the menisci, or the cartilage. These injuries can be isolated
but are frequently combined, and often result in the later
development of OA. About 10–15 years after an injury to
the menisci or anterior cruciate ligament, approximately
every other patient has developed radiographic OA [20–
23]. To increase sensitivity for patients with knee injury,
items were added to the WOMAC pain and stiffness sec-
tions and two new subscales were added, resulting in a 42
item questionnaire with five subscales; Pain (9 items),
Other symptoms (7 items), ADL Function (17 items),
Sport and Recreation Function (5 items), and knee-related
Quality of Life (4 items).
As expected, larger effect sizes of the KOOS compared to
the WOMAC was found in younger subjects (age 18–46)
with knee injury [5]. Increased sensitivity of the KOOS
compared with the WOMAC was also shown in previ-
ously meniscectomized subjects with and without radio-
graphic knee OA aged 38–76 [7]. However, a more
unexpected finding was that larger effect sizes were found
for the KOOS compared to the WOMAC in elderly sub-
jects (age 43–86) treated with a total knee replacement
because of severe knee OA [8]. Increased sensitivity may
yield larger score changes over time, resulting in larger
effect sizes. This in turn may allow smaller patient study
groups when comparing treatments.
Conclusions
KOOS was developed as an extension of the WOMAC
Osteoarthritis Index with the purpose of evaluating short-
and long-term symptoms and function in young and
physically active subjects with knee injury and OA. The
questions of the WOMAC LK 3.0 were retained so that a
WOMAC score might be calculated separately and com-
pared with the KOOS score. As expected, larger effect sizes
for KOOS as compared with WOMAC were shown for
young subjects with knee injury. The use of KOOS with
different patient groups is supported by the available liter-
ature. However, further use of the instrument will suggest
areas that need to be further improved.
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